Methotrexate megadosage followed by folate rescue. I. A study in clearance patterns

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Oncology
• Clinical Pharmacology

Background:

• High-dose methotrexate (MTX) is a critical chemotherapy agent.
• Understanding MTX clearance is vital for optimizing dosing and minimizing toxicity.
• Patient-specific factors influencing MTX disposition require investigation.

Purpose of the Study:

• To determine plasma clearance rates of high-dose methotrexate (MTX).
• To explore the relationship between patient characteristics and MTX pharmacokinetics.
• To assess factors influencing MTX maintenance concentrations and potential toxicity.

Main Methods:

• Pharmacokinetic analysis of plasma MTX concentrations in five patients.
• Administration of a 3,000 mg MTX infusion over six hours.
• Implementation of folate rescue 24 hours post-infusion commencement.

Main Results:

• Plasma clearance rates of MTX were determined.
• High MTX concentrations were maintained in patients.
• No correlation was found between age, body weight, or surface area and MTX levels or toxicity.

Conclusions:

• Patient age, body weight, and surface area are not predictive of high MTX concentrations or toxicity.
• Further research may be needed to identify other factors influencing MTX pharmacokinetics.
• Optimizing high-dose MTX therapy requires a deeper understanding beyond basic demographic parameters.